Incretin-NMDA receptor antagonist conjugate (Ousia Pharma)

N/A

Report date: 2025/06/05 16:35:35
NME

Base Information

Drug NameIncretin-NMDA receptor antagonist conjugate (Ousia Pharma)
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOusia Pharma APS
China Registration ClassN/A

Develop Information

Active CompaniesOusia Pharma APS
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A